Your session is about to expire
← Back to Search
Behavioural Intervention
Incrediwear Back Brace for Lower Back Pain
N/A
Recruiting
Led By Akhil Chhatre, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has undergone treatment for an initial episode of nonspecific low back pain (LBP) lasting > 1 month, with one of the following causative 'Principle Diagnoses': Disc herniation, Facet arthropathy, Compression fracture, Spondylolisthesis, Sacroiliac joint dysfunction, Scoliosis, Mild to moderate central spinal stenosis, Lumbar spondylosis, Degenerative changes, not otherwise specified
Subject report a VAS pain score at the time of consent greater than three (>3) out of ten (10)
Must not have
Diagnosed peripheral arterial disease
Higher functions do not enable proper comprehension of protocol or reliable data recording
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Summary
This trial is testing a special back brace from Incrediwear on patients with chronic low back pain who don't need surgery. The brace aims to support the lower back and improve blood flow, potentially reducing pain and improving movement. The study will evaluate the effectiveness of this brace.
Who is the study for?
This trial is for adults over 18 with chronic lower back pain from conditions like disc herniation or scoliosis, who use pain meds at least weekly. They must have had initial treatment lasting more than a month and report significant pain. Excluded are those with severe spinal issues, recent back surgery, diabetes, work-related injuries, or inability to understand the study.
What is being tested?
The trial tests if Incrediwear's Back Brace improves adherence, satisfaction, reduces pain med usage and functional disability in non-surgical patients compared to a sham brace and standard brace. Participants will wear different braces during the study period to measure these outcomes.
What are the potential side effects?
While not explicitly stated for this device trial, potential side effects may include skin irritation under the brace area due to prolonged wear or an allergic reaction to brace materials.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been treated for back pain due to a specific spine condition.
Select...
My pain level is more than 3 out of 10.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with peripheral arterial disease.
Select...
I might struggle to understand or follow the study's requirements.
Select...
I have a severe narrowing of my spinal canal.
Select...
I have weakness in my legs.
Select...
My lower back pain is due to inflammation, a tumor, or an infection.
Select...
I cannot take certain pain relievers, anti-inflammatories, or anxiety medications.
Select...
I have diabetes.
Select...
My lower back pain extends beyond my knee or comes with nerve symptoms.
Select...
My lower back pain is due to a work-related injury.
Select...
I have had spinal fusion surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Brace and sleeve utilization
Functional disability status as assessed by the Oswestry Disability Index (ODI)
Pain as assessed by the Visual Analogue Scale (VAS)
+3 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Incrediwear DaytimeExperimental Treatment1 Intervention
Incrediwear back brace worn 7AM-7PM (against skin)
Group II: Incrediwear 24 hourActive Control1 Intervention
Incrediwear back brace worn 7AM-7PM (against skin). Incrediwear waist sleeve worn 7PM-7AM (against skin)
Group III: Incrediwear Sham DaytimePlacebo Group1 Intervention
Incrediwear sham back brace worn 7AM-7PM (against skin)
Group IV: Control DaytimePlacebo Group1 Intervention
Standard-issue brace (e.g. Horizon Lumbar Brace (Aspen Medical Products, LLC)) worn 7AM-7PM
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Lumbar supports and braces, like Incrediwear's Back Brace, work by stabilizing the spine, reducing trunk motion, and providing support to alleviate pain. This can help reduce inflammation and prevent further injury.
NSAIDs reduce inflammation and pain by inhibiting enzymes involved in the inflammatory process. Physical therapy focuses on strengthening core muscles, improving flexibility, and promoting proper posture, which can alleviate pain and prevent recurrence.
Multidisciplinary approaches, including psychological therapies and education, address the biopsychosocial aspects of pain, helping patients manage pain more effectively. These treatments are crucial for back pain patients as they offer non-invasive options to reduce pain, improve function, and enhance quality of life.
Cell therapy for the degenerating intervertebral disc.Regarding the controversy of lumbosacral supports and braces - an update.Lumbar motion changes in chronic low back pain patients: a secondary analysis of data from a randomized clinical trial.
Cell therapy for the degenerating intervertebral disc.Regarding the controversy of lumbosacral supports and braces - an update.Lumbar motion changes in chronic low back pain patients: a secondary analysis of data from a randomized clinical trial.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,326 Previous Clinical Trials
14,874,629 Total Patients Enrolled
12 Trials studying Back Pain
4,364 Patients Enrolled for Back Pain
Akhil Chhatre, MDPrincipal InvestigatorJohns Hopkins School of Medicine
3 Previous Clinical Trials
95 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger